Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. | EVP, General Counsel | Common Stock | 21.1K | $2.11M | $100.13 | Mar 10, 2025 | Direct |
Sarepta Therapeutics, Inc. | EVP, General Counsel | Stock Options (right to buy) | 16.6K | Mar 10, 2025 | Direct | ||
Sarepta Therapeutics, Inc. | EVP, General Counsel | Stock Option (right to buy) | 4K | Nov 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SRPT | Sarepta Therapeutics, Inc. | Mar 10, 2025 | 3 | -$49.2K | 4 | Mar 11, 2025 | EVP, General Counsel |
SRPT | Sarepta Therapeutics, Inc. | Mar 7, 2025 | 2 | -$153K | 4 | Mar 10, 2025 | EVP, General Counsel |
SRPT | Sarepta Therapeutics, Inc. | Mar 4, 2025 | 2 | -$59.2K | 4 | Mar 6, 2025 | EVP, General Counsel |
SRPT | Sarepta Therapeutics, Inc. | Mar 3, 2025 | 1 | -$40.6K | 4 | Mar 4, 2025 | EVP, General Counsel |
SRPT | Sarepta Therapeutics, Inc. | Nov 26, 2024 | 2 | $0 | 4 | Nov 29, 2024 | EVP, General Counsel |
SRPT | Sarepta Therapeutics, Inc. | Nov 26, 2024 | 0 | $0 | 3 | Nov 29, 2024 | EVP, General Counsel |